N
Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:gme1000+pope francis200+nicolò tresoldi500+michael olise1000+bank of america fine1000+club brugge500+rb leipzig200+saudi news1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Bayer Announces Phase III" (30 stories)

Top Headline Story

Investigational PET Tracer from Bayer Met Primary Endpoints in Phase III Study
Lead StoryBayer Globalgeneral
May 7

Investigational PET Tracer from Bayer Met Primary Endpoints in Phase III Study

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQZ0hXUUZES2xhU2RBSTNWeEtTT0wzNVJCS0ZhYk12MXBhT09NM01GRWpIbHVvbUVSQXY5MXJtaTl2Y3diU1NMM0J6NDhrejI4UWJYRjFXV3FxMU5tTWg1ZlkzQVBVM0RwTEthaHFPZ0JoVExHT2N0UEhBNDhDOE5OZURTU1didEsyLXNMQms5Qk5ja1pVd2g2MjB4aXhIUHdfYmowUmlzZU5UMlRCRERESDltQQ?oc=5" target="_blank">Investigational PET Tracer from Bayer Met Primary Endpoints in Phase III Study</a>  <font color="#6f6f6f">Bayer Global</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+20m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

Filter stories
200+20m ago

pope francis

The Myth of St. Francis

Filter stories
500+30m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

Filter stories
1000+30m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Filter stories

Search Results for "Bayer Announces Phase III"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer
Diagnostic and Interventional Cardiologyworld

Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQR2FkdkFmSnc3UHAyOHhDZFNZLWRoN0RHQmtpMmlmMkZodUlvclNoRlRXYmtKR0FRaVN3S282dXNKRktHWURZZS04Z1JNaTBLaWFZLUpia2hFTm9mbm1jTUg0Ynh1YzR2UUlXdG4tY0VZNVFacFR5dGlXYXBmU1djZ2J3T0dTNldzNElaRS0wQTV5Qi1tWWNlQmZrWGtQaTA3NnhwVVM2U0hTX00?oc=5" target="_blank">Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer</a>  <font color="#6f6f6f">Diagnostic and Interventional Cardiology</font>

Read Full StoryMore like this
Bayer Announces Positive Data for Investigational PET Radiotracer
Imaging Technology Newsworld

Bayer Announces Positive Data for Investigational PET Radiotracer

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPdjlyMlotaDMtTF9PWGh3eG13Y1ViX3ZUWFVtcFRCLWdPYkRjWExybWtqVlFCay1BaXZCdXpWcGZWYWVVaHdIYnVxSThSRDZZcU5WbnJETUZheDlFMFFQd016WHJyaW1XUHpFVmU4TU5ISWJrbGREMG5LRmJac0M3T0o1Ui1UNHRTZ2Z0ZURiVGVsSFNkX01RbUtZVQ?oc=5" target="_blank">Bayer Announces Positive Data for Investigational PET Radiotracer</a>  <font color="#6f6f6f">Imaging Technology News</font>

Read Full StoryMore like this
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Bayertech

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxNcm8wNjlacndDenp6TEZNaEtxMFo3RG1fNXp3N0VhOXJlUnFHemFmTGREeXZHMWtVdmk5cDl2U19UQXRQaVBWU0dsRWFLUUE1X043Q0ptcWxKTExqNjdmZWZLV1o1blI1OHM0bU5aTllFM21KcDcyaUNWR0hONVh2aXJaVUpnTXh1cE5wTDQ2MDZrbjA0NVo5UzB4MDlwN192c0kxSjhJUHpNbnVuSk1Fbld1VGN0enVzT0pGWUEtWG1sUVI4bl9WZXR0ZTRiM0xoTlVhWUdyVDFPRzM4djdmOVRuSlVKejh0WnFsX1F5R3NOUQ?oc=5" target="_blank">AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure</a>  <font color="#6f6f6f">Bayer</font>

Read Full StoryMore like this
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
Yahoo Financetech

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNaUw5aXBwRENsUlkweG85clZ5X1U2U1ZIemZ0U3UtZXB5aDc5NThSVTdKdHZILUYyclVtcWE5RHpWNHJ0V1FNS1piMjlidkNpZThpZHh4ZFM1bTJSWUVPT3ZOXzFMZ1dadWdxR1M4bjQtWm9BQ1ZhdmJmbFZnZzJuMjBhYm5McnhqTnJqVTF0X0NMU1hscURjRDE1YnBsYzNHZmJ4dVZSOThHUFdH?oc=5" target="_blank">Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
More than 60 million people have AFib, an irregular heart rhythm. Bayer tests a potential treatment.
Stock Titangeneral

More than 60 million people have AFib, an irregular heart rhythm. Bayer tests a potential treatment.

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQQTMzV3lIb2szSXA0OTlLZ29HT291d08yZDhLdFpSTGhNbmhUWEliZGN0LXhLQkFoMk45eVhoWWVaUVg0TjY5Qk0wSE5oN21mbHJDNUk3YXllQkw3WnRqa2Q4RXBtSUdRS3hIZVRvQjRMSVYxc25EY3JsdGNQb0JNTHJHQjFlZnpzR1RFclVHcEExVTMzajQ1VG1lS25TUkZBdm9wRHR3bDlhcUJJZDVfUDFJdS0tSmpHUnhIYi1xY2NRZw?oc=5" target="_blank">More than 60 million people have AFib, an irregular heart rhythm. Bayer tests a potential treatment.</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline
Business Wiregeneral

Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQbE1RYnN1a1FmTjctZ1Q2Qnd5blZ4dTFURjVkX01Sd3RmdHVwRzlPeEN5Y19nVEhTQnZ3MnkzUEhLaF9vUjRPRS1ucm9jckcwa1lmdk9GbVotd2ZTRExmTkNaV0pvRG9oLTNDTFJXNDlhTFdxQW52VWlNcUtSVjZCdEd0bC1wR0xscW1weFQ3b2s3bTRud3owbUJ5MUVrVHhlSURFcTF3aWtYeHJhLTJDWGFITHU3ZWpfYnBxcEJXN1Q1N0hLbmZUdThQYw?oc=5" target="_blank">Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Bayer announces positive pediatric trial results for gadoquatrane
AuntMinnieworld

Bayer announces positive pediatric trial results for gadoquatrane

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPamJHcE1SVVFKOF9jV0JNbUJuc2ozOG90R2J3N3NaUjZ6dDB5bEVIQ244bHJvMGdMOEVxOTVlYktBYjN2NjNQbXJvaWFYREo1ZEttVWM3VG14TnJCN3ZEYm4zdXdxcUY3YjZ3SE9ndk5pRDlLWTBKczYxSmRwaFBtZFoyYTRsWHdpYXRSckNacV9mWXpSZzBGRUNoQzhYU1Fvb0NGbGFMZXhsRFVCdTYwSFNNazFITkt5VlhfS045bDkzdw?oc=5" target="_blank">Bayer announces positive pediatric trial results for gadoquatrane</a>  <font color="#6f6f6f">AuntMinnie</font>

Read Full StoryMore like this
Phase III FIND?CKD Results Show Bayer's KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non?Diabetic Chronic Kidney Disease
Lelezardgeneral

Phase III FIND?CKD Results Show Bayer's KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non?Diabetic Chronic Kidney Disease

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxOVjZOMnNzZklIQ3d2RUJNSWZFdGlLV1lTTTJsa0piZGVxd3hUenplLWRXdGItdF9Bc2Vqb0NWWlI5dDV6ZGU1Snc1Y0JGSVJWS0IxTVFsaW9VRzNPM3AtU1ZRUkxPbFg1bU5pYURDanhKSHlHajZhWFozUWN0Rm56NndZYnJiUEpaNWZLaHF6cDJodFZBSjdRY1p6RTloX1BHdmt2M2tyZnh0UzdlZlVXcmV6MHU5YjRkQ01lNHB6VDA1NTB5Y1VTNzNxZ2ppVmIyX0Rz?oc=5" target="_blank">Phase III FIND?CKD Results Show Bayer's KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non?Diabetic Chronic Kidney Disease</a>  <font color="#6f6f6f">Lelezard</font>

Read Full StoryMore like this
Bayer picks Kacy Perry to lead 550 crop science staff in Canada
Stock Titanscience

Bayer picks Kacy Perry to lead 550 crop science staff in Canada

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOenBTbVY4cU5BenlXWWxSakZPYy02c3NBOXJwcmlXSWlUVkd5UDVkQmxyeldiaDNjNV84NG80RkxRQzFJLWZCb3podVhfOTBWS2tZRkhYQ2F2TDJBdHRncXJDN2dsanlnMUZjV3dHdXFIQlFjTVNBeFhjZmg3U2pmYWVGaXpCbFd3ZDl0ZnFxeFd1aS1iMlhZOWF5ZmNpNUNlcGFTLVdQRGxiTDFzcTYwUG5VQ0F0cVpmMFNN?oc=5" target="_blank">Bayer picks Kacy Perry to lead 550 crop science staff in Canada</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia
Bayer Globalgeneral

Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNelJRc2d0NFdoVUNtaE9sSk5BaE1taHpaZmhjOEdNZGtGYXpYOW92VTJmX1BleTc0clZaRjJPWVFTdENHcGUwV0N3V2laQWNyWDkzRThPX3d3WnlNVG9TOUVOYlh2X3h6RDQ0ODE2Ni1nN25jVVZCSjR3ZFgwY0pTNEVvaEFwc1JHUDNvdGJxUDRUaG43OGMtRVZKWElURDQ0bGR0cnkwZ3AyWElPMEpuUXFoTWdxMVB3OXI4RC1XMGFsc1lGTnM4VEN0QWx2dUNVZFBOdzF4U3pyZw?oc=5" target="_blank">Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia</a>  <font color="#6f6f6f">Bayer Global</font>

Read Full StoryMore like this
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
Business Wiregeneral

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxPUUExYk90VHI0ZnZKQ0NveHgwRm56NHQzOE1jRjRDUGs5MkNmQzluS2lrU0RxS3FhNjZOSHY5S0hKN3ZkZWxhYTlrQ0UxVE5kbTVUUVNfcE9yYmZxaUtnZFZQQzYxTzJrM2ZQd3Z2dV9wdGJXeUlZNHNVOTJZbzhmN1p4SnVYMGgyUlpaUVM2S1lfSWc5WDBwQ3NJZ0l3Yl9uQkVoMkIxaDc5Z1hJX2RhQ1MzZVJsX2dlUV9Ielp5R1o1Q1REVFRlZHRsU19iVzBrdzRrdjh1Q2FhMW15XzFxOG5ITTEtWFJ1VDI1ZzdBYw?oc=5" target="_blank">Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Bayer Initiates Phase III Study Program for Investigational Oral FXIa Inhibitor Asundexian
Business Wireworld

Bayer Initiates Phase III Study Program for Investigational Oral FXIa Inhibitor Asundexian

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPbDE2RDJQRjhYa0xDdnF1bkdSd1RjT0hMdDNPallKVGV3WHdjUTlleWVyUm9JWG9wT0R2ZHZjZzZydDB0dFFNTkFDaFlfaG9wdTl6elM3RHVrdG9EbFNHZC1USC1HUEJwQm1udkJiNDhFbmxJZ1J2TEFieVgtX3A1MHpYNWoyLUpJWTc0Z3dCY2RzN3hSb0h1Q1JIZE1nWGtDYUE2ZlUxcmJ1RlpaWEt0R1dRNDI5UXU2Z0Nhd3BTc1dLOTJKeFhfZ250cnoyLThPazdCc05Gc3NfMGZwdFRaTQ?oc=5" target="_blank">Bayer Initiates Phase III Study Program for Investigational Oral FXIa Inhibitor Asundexian</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
Bayermarkets

Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant

<a href="https://news.google.com/rss/articles/CBMi_wFBVV95cUxOT1V4aHR3VWF2VzVCN0NtR0tLTXduN2tkRVlQWkhDaWFLM3RlQjJvaE5fVnlsOEhVa1J1VDR4bHI4eFlpZjdOak1tQ1p1OTY0RXZ2OHpTYU4zSnhDV1Bod1h4RVF1NVFYcHdaZlN5QzZKQy1rNjlHVkRQMHNTMzZfNmRLZDFWWkZKZm9rSnA4OFNLV0xOLV9nU1djVmJkclB1b05LNzlhOFhlS1RKeW40T2QwQUpFbXpLUzBORzBuUEtUeGpYOTltd0FiT1dGQ1FKVFRid2p0bXpfWHotZ1BmODQxN05nOHdEZXIxYjZWSjM1UTQxRHFpbjlvTkI3NVE?oc=5" target="_blank">Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant</a>  <font color="#6f6f6f">Bayer</font>

Read Full StoryMore like this
BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial
Bayergeneral

BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial

<a href="https://news.google.com/rss/articles/CBMikAJBVV95cUxNV1RYaDlhNUgwaUk1QjRuakZ2ZGo0WGFNMGpHZVhYenZTX3JiZFZRRzNONTBfMHRSNS1GY18tYUFUSkJla2Uzbkl5aEZWSW5xT25KVF9DQjJGZ013UVppYlNieF92WDJUSDJSZzJ3cVJfUTVNQUU5UUhoR1FqdWZIWUdYYkM5SnZXbi1mMHBreDF1MXFuRDkxblJka2QxRHUxdUVsNzM0REtSN3l3M3UzZlAwdVdpVTUtSHJ3cHFheGYwSGJVUW53emxpWnVCbkRva0kzN2pqN1hXZ3BxNHVFZFRnVTh5Q3htWVlfdkRRYnZ0Vy1WcXF6RF8xaUoxLXY0X2tBX2lfdUJnWVQyTVRIcA?oc=5" target="_blank">BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial</a>  <font color="#6f6f6f">Bayer</font>

Read Full StoryMore like this
New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment
Bayer Globalworld

New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxNbDRQVW8xU3N6bDNzNVJZdElndlhqa3lrWW9MYi1UUGh1WHN1ZFZYUmdJMmcxcHF6NHVMTnBaaGF4WFNYWVpyUlpmLThlbEF1dzNpckM1dGR6WXNnNGw2X2QwZ1MtQk5hc3dqa3kzeFYyRXNnNlJCQVhrRC1SLUNfYUxEamt5OHZ5MTd6NWNJekdGRFVFMTB4RFkzWFYtcGdYNXl6aXpTOG9nTHNfSW1sN1RQU2N6UEhxM25sUmpWOTdPaFNkUGljWVRQVFYxRkxkNXEzcmdocXhwM2RQXzBXYk5VYl9rVnM4SWc?oc=5" target="_blank">New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment</a>  <font color="#6f6f6f">Bayer Global</font>

Read Full StoryMore like this
First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel
Bayergeneral

First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxQcnFHN0hIR25ZOHVCZmttTXFNMEhjQ09vS29BV3RlSjBKelJ3Slc2dEFSX0Y1Uzd5TU5OZ2tGeV9mZ2VDUlo3eHNjaC1vX21Qa0haaV8xNUtDRXlfWGR6R3k2TWdVUjliRXlvaVJYMFVZdFFFdDNrVm9DNjFSTzQ2SmVaMmF3R1B2UFZXXzBHTF92ZndRb0lYMmFSNUZhaVZUb3NJbE43TGVHdXZoV1Izd01xcGJLVnU1RE9MMGxZcE5najRFakNqeFF5VU1rLXhwLUFtTDZDR2l4d09seHdIa2t3LXhKRUtISVRPcGpBOA?oc=5" target="_blank">First Parkinson’s disease patient treated in BlueRock’s pivotal Phase III trial of investigational cell therapy bemdaneprocel</a>  <font color="#6f6f6f">Bayer</font>

Read Full StoryMore like this
Bayer starts Phase III trial in non-small cell lung cancer (NSCLC)
Bayer Globalworld

Bayer starts Phase III trial in non-small cell lung cancer (NSCLC)

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPNURCNG5zZ2JmMWxpLUJIZ1VSVEN3WFdfdzRZMjczWjRqTjF0Zi13YnduUWFrcmNFNEc5SHpaczF0YkMtX0YzUmd3cmR0X181XzBUZEl5bVJFcDNQWWJVeURIYmh0MjFtXzBPdG1TODU3OE5ZdFlMWnJsMnRGOUVqUDNnc2dWVy1jcW42UlVHX09fcnZvUDd6OTJXREtkM3Va?oc=5" target="_blank">Bayer starts Phase III trial in non-small cell lung cancer (NSCLC)</a>  <font color="#6f6f6f">Bayer Global</font>

Read Full StoryMore like this
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure
Bayer Globaltech

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

<a href="https://news.google.com/rss/articles/CBMilwJBVV95cUxQSlFWRE1GUzJFNDdhUTNXd09zSW9NUFhxVHd3UlpIZjVwMHR5R1FFcExPNXlzd0JwWEdRWUphRWF2OTJlWWw3dGpqa3lLeGVzdnNHSlo0Zy13WGRPY3dDZ0RQYVVOaUhWcU54WlplTzliZGVHVVFKSU9qM0dsRFdQelZYZU0tVEFmZVhyOHJGVjczNWtaVTNqMk1uaHBXVi1DLTRDYWFuazBhWWlLdWpPU3FsVUpFSHphMVpZb041UFVWcnFtc2lUUC1iYlBVZllZZWFSc3MzaE83R3N5MXVtWUlpbmJsaEhPN3diTC0yYllvVkVEMU5ZZ0FXMDQ3QTFGRG50SkVIN2NvOXg3RXRvU0xON0RrMTA?oc=5" target="_blank">AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure</a>  <font color="#6f6f6f">Bayer Global</font>

Read Full StoryMore like this
Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease
Bayertech

Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPMlBkd01QRVJ2SGVsQXVfQ3BOcWJjMjRlSTB3M3VmRC1ING1GRDc5NXM5SVNRRTZIdmt4WVZWZnhVSnJEMnVXUnFrRGNyWmZINzVPSnphVzdLWkx1eF9Cb3FLZHcxLUg5U3ZSWXpQMHdLak1HUDg3eUpzZ1VWSFJ5ZTRubXZOSzZTeG9YajIzQUE3N3pTNngwejVESjlUcjNWek5VZGU2X1Qxa2RwNkE0LWdKbEZ6N2I5MHAwT2M4VGJKNDRmQTBidA?oc=5" target="_blank">Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease</a>  <font color="#6f6f6f">Bayer</font>

Read Full StoryMore like this
Bayer’s Finerenone Hits Primary Endpoint in Phase III Heart Failure Trial
BioSpacetech

Bayer’s Finerenone Hits Primary Endpoint in Phase III Heart Failure Trial

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQcDl0dnhfN1RTVGstYjhZYmVHUVhPNXh5Z05UVUxvaUVicFdtUVF3bWg4clh4U0RQUlZpZ3FGTEhINmFyWnB2LWZmNHo3ZVVzc0V0QUh3alJZdHh2eW0zWC1mdllGM1hmOElLck9VVHJGUHR6dThNallrMlZUNDRkemZQaXYyWk5mRDRfeGx2cTFWNkFEYlRFOGcyNmV5Um5mOUsyQnF3NFRHb3U0N3k3Y3pQWDM?oc=5" target="_blank">Bayer’s Finerenone Hits Primary Endpoint in Phase III Heart Failure Trial</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances
Business Wiregeneral

Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQzZDQkgyaFFRVHdZOEFsaEk1aFRPMGZSNHhSVnVfR2pIMENqZXdqMFl2UzBpcWlSODJNZ3BzSThfeGtWVWhaRkVGYmRBbmQwVTlRTHZPbEJKLTJfTV92R0hkX3ZqbWxCVWZNSmpva052S3VDNUZrVzM1SFEyaUpLUWotakNXMlVreWtMaUkySFl5bHBVeUZXa0s3a1phU2dWTnVWWTVBQUtCbU1mLXlWZTdtOHNON2loMDdBdEhaZHJSUQ?oc=5" target="_blank">Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
Business Wiregeneral

Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026

<a href="https://news.google.com/rss/articles/CBMi_wFBVV95cUxOVWRGeHNoVklYVHBiQjZuLVFzand3eWphLUZrdVhuV2Z1aFlfSmxNbU9aT05lTmRjbzVsU2lBWWliN3dHRFY3SUZVRm41clNDZE9BcThrTVAwU0VJWENRU3JQZG5vbUJxU1dCQmlVcHh6dDl6Z1ZURWpqMDR2aWlDeUtKSjYwaDhXVUg2dTR1S3NVWFZrTUY5a1Y5UXM5c29iT1JMbkViWnVtbFdTZEVESzNydUk4bUcwMFpZaExDc0RPRFJqREdZY0lhcmJCYkJtWnFWYm96eTdOdk5UVU03NlpoaDZfSGFHNEpoMVU5N3JuLURMWm02NDdaUXJsaXc?oc=5" target="_blank">Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
UCHealth, Children's Hospital Colorado and CU Anschutz Announce Clinical Trial Partnership with Bayer
SoCo Digestscience

UCHealth, Children's Hospital Colorado and CU Anschutz Announce Clinical Trial Partnership with Bayer

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOUmJuejFyZllybHZwWlBWNlJ1S2dVMmRTVTZEck5fWGpuUExuZVgtaUJ0QllPdVc4UC1takg0aDRjd3RFaHQ5RTJBRUxQRk50a0J2LUdhb1pRUjZTVl9EeTdxM043MS16aVVralplQVc3QXNTWEdtQWV5N0UzRk12cmJBRjY1d01aZzBmWEo1UGI3WGdm?oc=5" target="_blank">UCHealth, Children's Hospital Colorado and CU Anschutz Announce Clinical Trial Partnership with Bayer</a>  <font color="#6f6f6f">SoCo Digest</font>

Read Full StoryMore like this
Bayer Announces Positive Phase 3 Data for Stivarga
drugdiscoverytrends.comworld

Bayer Announces Positive Phase 3 Data for Stivarga

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQcVZ5bW9tVHdhWVVXazhJbDdYZVRsTVJxaUc5dkJIbTVIU0xGbjI1emRiUnhqeEFHcUYwb2VPNHhvWk9lV3FQdkMyWWNkclFKMVcwQmZNQUFyRkVPYlRybmRUNlBnZUt0ZGpQb0l3WU1jZTBYWWpBbC1JZ1hIR0RFN09nWjktSVNmYkxjdlJJOE8?oc=5" target="_blank">Bayer Announces Positive Phase 3 Data for Stivarga</a>  <font color="#6f6f6f">drugdiscoverytrends.com</font>

Read Full StoryMore like this
Bayer launches phase III studies of gadoquatrane
AuntMinnieworld

Bayer launches phase III studies of gadoquatrane

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOQ1g1bTlzVDhoVTl4alowdHdMT19vcm5HMWpHX0RyZU5fWDkyYTdhRGhHZXdUM3ZGWnVyMDVLQUlPU090VU9CQTZ6VkJKUUFSX09EaTI3ZmUxT2tJVGo0THRKTUIwOUNMR3duS2NnRWIwRm4tcUNHQmRBemVkel9SV1ZVemFLcTBRMzBtVTJpQ2NOeG5JbnRET1hLRlB5OTNHR0kydFpKWVZkLVdJOEQ4?oc=5" target="_blank">Bayer launches phase III studies of gadoquatrane</a>  <font color="#6f6f6f">AuntMinnie</font>

Read Full StoryMore like this
Bayer Halts Asundexian AFib Trial, OCEANIC-AF, for Inferior Efficacy
HCPLiveworld

Bayer Halts Asundexian AFib Trial, OCEANIC-AF, for Inferior Efficacy

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNLVVNT3EyRnRHSmZUci1wcVNINEhWSGV5ZlNTakUwQkl1MU9TdzliVVpsN1phTnRWRmtxM216dTdFRVdJRnBQa0F5UkY3d3JHelphTTA2aC01dGNGaEVVT0lzZG8yRUVyRzc1am9OV0NaMXVHODN3Q0h3Q29kcEI5UExfLUcwZmEyV1NpVnlHaDBCY2tFQnpmbGtuLUM?oc=5" target="_blank">Bayer Halts Asundexian AFib Trial, OCEANIC-AF, for Inferior Efficacy</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
NUBEQA Meets Primary Endpoint for Phase III ARANOTE Trial in Men with Prostate Cancer
Applied Clinical Trials Onlinegeneral

NUBEQA Meets Primary Endpoint for Phase III ARANOTE Trial in Men with Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNVzE5OXFhaEVPbUhIQV8xSHA4SkpueWtxUXRpNXRKWldMYWhlMzZDdi1VNzJsWnRRSW9WbkN0d2FIT1RrMjlJTEJJdWNPUFlXSHJKSnJBM1NXUVFIaUpfbUJlMWczaVpWenFZYktpRDhrSGQ0TGp3SFk2NkhjMnN5MGpkQ1l5ZzJ6M09lRWdBSHlZM0JkTUNhUkY1dmlZa1BIRC01MGpUWUdKNkd0enZXMXFicWR5TnM?oc=5" target="_blank">NUBEQA Meets Primary Endpoint for Phase III ARANOTE Trial in Men with Prostate Cancer</a>  <font color="#6f6f6f">Applied Clinical Trials Online</font>

Read Full StoryMore like this
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
BioSpacegeneral

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOQ0RiaTZZbk5ob2hGWncwVTZrdjlqLXN4TE1EejZ6OTMzelBEU3ZBZ3ZXNjNzMk0xSXRZVjhhanAwckZ6NnZmMjg1cGxVaUNVSUp4STlWTU83d01RNk5qOUt1X2VFWURyNEJqWkJjQlFWTl9kUnhYY0h0RURKaHc0N0lqZl9MdUtCY1FfQUpmeDlKc2V6QVBlNXZjY3czMTdERi1fcVdn?oc=5" target="_blank">Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF
TCTMD.comgeneral

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQY2dXVkMxZmUxZk05RWRkYkxacG5fQ1FtejlJWVczX0VHRGYxWW5qQmpmXzFZUjlXektkRG56VGpIbzFZZWhSanEzQ0dKTW1hczZZeTFsX1ZhUjBPRmNPX1U5eExEU0hMTlZiOG0xTkRFcHhXNWNjaVE0YkVsa0g0TndmVm96NmU1M29nZHo2Z1pYV1NXa1IxMXFfWVdRRk1YU2RIUHRFalVKRjZLMUE?oc=5" target="_blank">FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
"Bayer Announces Phase III" — Live Google News Trends & Headlines